Ouverture: | - |
Variation: | - |
Volume: | - |
+ Bas: | - |
+ Haut: | - |
Ecart + Bas / + Haut: | - |
Type: | Actions |
Ticker: | ALBLD |
ISIN: | FR0004174233 |
BILENDI: Strong growth in Q2 2022
- 52
BILENDI
Strong growth in Q2 2022: +50.6% (+10.2% pro forma)
Paris, July 26, 2022 - Bilendi, a European leader in research technology and data, announces the release of its Q2 2022 and H1 2022 revenues.
In the second quarter of 2022, Group sales came to €15.6m, up 50.6% on the second quarter of 2021, marking the eighth consecutive quarter of double-digit growth. On a pro forma basis, as through the acquisition of Respondi AG had taken place on January 1, 2021, revenues were up by 10.2%. International business (78% of total business) was once again at the heart of this positive momentum, with revenues of €12.1m, up +53.5%. The Group benefits from a strengthened presence in Europe, with the opening of a new office in the Netherlands[3] and increased visibility in Germany, where Bilendi is one of the key players in the largest market in continental Europe[4]. In France (22% of the activity), growth remained strong, with revenues of €3.4 million, up 41.2%. For the first six months of the 2022 fiscal year, Bilendi recorded consolidated revenues of €29.0 million, up 51.2% (+11.4% on a pro forma basis). This growth is even more noteworthy as it is taking place in a generally uncertain economic context, demonstrating once again the resilience and robustness of Bilendi's model combining technology and data. Since the acquisition of respondi AG on November 22, 2021, the integration has proceeded according to plan. The quality of the team, the database, and the customer portfolio from respondi are fully contributing to the development of the Group in Europe.
2026 objectives confirmed The Group is reaffirming its aggressive growth strategy, combining organic development and targeted acquisitions, with the objective of reaching revenues of €100 million by 2026, and EBITDA of 20% to 25% of revenues, i.e. €20 to 25 million.
Next publication: results for the first half of 2022: October 4, 2022 (after market close)
About Bilendi At a time when the amount, variety and speed of data being issued and communicated are increasing exponentially, Bilendi provides an innovative technological response to the collection, processing and enhancement of this data. That is why Bilendi is positioned at the epicenter of data collection for two market segments. These are: Technologies and Services for Market Research and Technologies and Services for Customer Engagement and Loyalty. We have locations in France, United Kingdom, Germany, Switzerland, Spain, Italy, Denmark, Finland, Sweden, Belgium, Netherlands, Morocco. The group also has business activity in Austria and Norway. In 2021, Bilendi achieved a turnover of € 44.1 million, € 57.9 million on a pro-forma basis. The group is listed on Euronext Growth Paris. ISIN code FR 0004174233 - MNEMO code, ALBLD - Eligible PEA PME.
Contacts
[1] Proforma scope 2021: as if the acquisition of respondi had taken place on 1 January 2021 [2] Integration as of 1 January 2021 of 100% of Humanizee SAS, which owns the Discussnow platform and as of 1 December 2021, of 100% of respondi [3] Press release of June 2, 2022 [4] Press release of June 22, 2022 Regulatory filing PDF file File: Strong growth in Q2 2022 |
Language: | English |
Company: | BILENDI |
4 rue de Ventadour | |
75001 PARIS | |
France | |
E-mail: | [email protected] |
Internet: | www.bilendi.com |
ISIN: | FR0004174233 |
Euronext Ticker: | ALBLD |
AMF Category: | Inside information / News release on accounts, results |
EQS News ID: | 1406401 |
End of Announcement | EQS News Service |
1406401 26-Jul-2022 CET/CEST
EQS Group est un leader mondial de solutions digitales pour la communication financière et corporate et la compliance. Plus de 8 000 sociétés dans le monde font confiance aux services d’EQS Group pour s’adresser de façon efficace et sécurisée à une audience nationale et internationale de partenaires et pour se conformer aux directives et obligations réglementaires.